Stay updated on Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T04:56:33.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. This appears to be a minor site update with no changes to the study information displayed.
    Difference
    0.1%
    Check dated 2026-03-11T23:27:06.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    A site revision tag v3.4.2 was added and a government funding status notice (and an earlier revision note) was removed; there are no changes to the study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:06:27.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapse and NIH Clinical Center status was added, along with a version update (Revision: v3.4.1).
    Difference
    0.5%
    Check dated 2026-02-04T10:12:20.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added a glossary toggle and minor wording/capitalization updates to QC labels and the revision text. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:01:32.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed Revision: v3.3.3 on the page.
    Difference
    0.1%
    Check dated 2026-01-14T02:10:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Neuroendocrine Carcinoma Clinical Trial page.